The mdm-2 Oncogene Can Overcome Wild-Type p53 Suppression of Transformed Cell Growth

REFERENCES

• Bartek, J., R. Iggo, J. Gannon, and D. P. Lane. 1990. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893–899.
   PubMed Web of Science ®Google Scholar
• Choo, K. H., G. Filby, S. Greco, Y.-F. Lau, and Y. W. Kan. 1986. Cosmid vectors for high efficiency DNA-mediated transformation and gene amplification in mammalian cells: studies with the human growth hormone gene. Gene 46:277–286.
   PubMedGoogle Scholar
• Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547–556.
   PubMed Web of Science ®Google Scholar
• Eliyahu, D., N. Goldfinger, O. Pinhasi-Kimhi, G. Shaulsky, Y. Skurnik, N. Arai, V. Rotter, and Μ. Oren. 1988. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3:313–321.
   PubMed Web of Science ®Google Scholar
• Eliyahu, D., D. Michalovitz, S. Eliyahu, O. Pinhasi-Kimhi, and Μ. Oren. 1989. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86:8763–8767.
   PubMed Web of Science ®Google Scholar
• Fakharzadeh, S. S., S. P. Trusko, and D. L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10:1565–1569.
   PubMed Web of Science ®Google Scholar
• Finlay, C. A. Unpublished data.
   Google Scholar
• Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093.
   PubMed Web of Science ®Google Scholar
• Finlay, C. A., P. W. Hinds, T.-H. Tan, D. Eliyahu, Μ. Oren, and A. J. Levine. 1988. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 8:531–539.
   PubMed Web of Science ®Google Scholar
• Gannon, J. V., R. Greaves, R. Iggo, and D. P. Lane. 1990. Activating mutations in p53 produce common conformational effects: a monoclonal antibody specific for the mutant form. EMBO J. 9:1595–1602.
   PubMed Web of Science ®Google Scholar
• Goldfarb, Μ., K. Shimizu, Μ. Perucho, and Μ. Wigler. 1982. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature (London) 296:404–409.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Halevy, O., D. Michalovitz, and Μ. Oren. 1990. Different tumor-derived p53 mutants exhibit distinct biological activities. Science 250:113–116.
   PubMed Web of Science ®Google Scholar
• Harlow, E., L. V. Crawford, D. C. Pim, and N. Μ. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigen. J. Virol. 39:861–869.
   PubMed Web of Science ®Google Scholar
• Hinds, P., C. Finlay, and A. J. Levine. 1989. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol. 63:739–746.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., C. A. Finlay, A. B. Frey, and A. J. Levine. 1987. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol. 7:2863–2869.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., C. A. Finlay, R. S. Quartin, S. J. Baker, E. R. Fearon, B. Vogelstein, and A. J. Levine. 1990. Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells: a comparison of the “hot spot” mutant phenotypes. Cell Growth Differ. 1:571–580.
   PubMedGoogle Scholar
• Hollstein, Μ., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49–53.
   PubMed Web of Science ®Google Scholar
• Houweling, A., P. J. van der Elsen, and A. J. van der Eb. 1980. Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology 105:537–550.
   PubMed Web of Science ®Google Scholar
• Jenkins, J. R., K. Rudge, and G. A. Currie. 1984. Cellular immortalization by a cDNA clone encoding the transformation- associated phosphoprotein p53. Nature (London) 312:651–654.
   PubMed Web of Science ®Google Scholar
• Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. A. Weinberg. 1986. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6:1917–1925.
   PubMed Web of Science ®Google Scholar
• Lane, D. P., and L. V. Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature (London) 278:261–263.
   PubMed Web of Science ®Google Scholar
• Lechner, Μ. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045–3052.
   PubMed Web of Science ®Google Scholar
• Levine, A. J., C. A. Finlay, and P. W. Hinds. 1989. The p53 proto-oncogene and its product, p. 21–37. In L. P. Villarreal (ed.), Common mechanisms of transformation by small DNA tumor viruses. American Society for Microbiology, Washington, D.C.
   Google Scholar
• Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumor suppressor gene. Nature (London) 351:453–456.
   PubMed Web of Science ®Google Scholar
• Linzer, D. I. H., and A. J. Levine. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen in SV40 transformed cells. Cell 17:43–52.
   PubMed Web of Science ®Google Scholar
• Michael-Michalovitz, D., F. Yehiely, E. Gottlieb, and Μ. Oren. 1991. Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T-antigen-p53 binding. J. Virol. 65:4160–4168.
   PubMedGoogle Scholar
• Milner, J., E. A. Medcalf, and A. C. Cook. 1991. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes. Mol. Cell. Biol. 11:12–19.
   PubMed Web of Science ®Google Scholar
• Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69:1237–1245.
   PubMed Web of Science ®Google Scholar
• Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (London) 358:80–83.
   PubMed Web of Science ®Google Scholar
• Olson, D., J. Momand, and A. J. Levine. Unpublished data.
   Google Scholar
• Oren, Μ., W. Maltzman, and A. J. Levine. 1981. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1:101–110.
   PubMed Web of Science ®Google Scholar
• Reich, N. C., Μ. Oren, and A. J. Levine. 1983. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol. 3:2143–2150.
   PubMed Web of Science ®Google Scholar
• Reihsaus, E., Μ. Kohler, S. Kraiss, Μ. Oren, and Μ. Monte- narh. 1990. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene 5:137–145.
   PubMed Web of Science ®Google Scholar
• Rogel, A., Μ. Popliker, C. G. Webb, and Μ. Oren. 1985. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol. 5:2851–2855.
   PubMed Web of Science ®Google Scholar
• Rovinski, B., and S. Benchimol. 1988. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene 2:445–452.
   PubMed Web of Science ®Google Scholar
• Ruley, H. E., J. F. Moomaw, and K. Maruyama. 1984. Avian myelocytomatosis virus myc and adenovirus early region 1A promote the in vitro establishment of cultures primary cells, p. 481–486. In G. F. Vande Woude, A. J. Levine, W. C. Topp, and J. D. Watson (ed.), Cancer Cells 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus ElB-58Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54Kd cellular protein in transformed cells. Cell 28:387–394.
   PubMed Web of Science ®Google Scholar
• Scheffner, Μ., B. A. Werness, J. Μ. Huibregtse, A. J. Levine, and P. Μ. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus 16 or 18 promotes the degradation of p53. Cell 63:1129–1136.
   PubMed Web of Science ®Google Scholar
• Stürzbecher, H.-W., P. Chumakov, W. J. Welch, and J. R. Jenkins. 1987. Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. Oncogene 1:201–211.
   PubMed Web of Science ®Google Scholar
• Werness, B. A., A. J. Levine, and P. Μ. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76–79.
   PubMed Web of Science ®Google Scholar
• Yewdell, J., J. V. Gannon, and D. P. Lane. 1986. Monoclonal antibody analysis of ρ53 expression in normal and transformed cells. J. Virol. 59:444–452.
   PubMed Web of Science ®Google Scholar